ACE2 and COVID-19: Interestingly, a common involvement of the angiotensin converting enzyme 2 (ACE2) in both lung cancer and coronavirus infections, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19), has been reported [11,12,13,14].